Pulsatile Perfusion Afterbirth Cell Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating stem cells from umbilical cord blood are inefficient, resulting in insufficient usable cells for transplants and research, and do not effectively utilize pulsatile perfusion or digestive enzymes to extract cells from afterbirth tissue.
Innovation Solution
The method employs pulsatile perfusion of afterbirth tissue using a perfusion circuit with a pulsatile perfusion pump and a solution containing colloidal, anti-edema, antioxidant, and anti-inflammatory agents, followed by enzymatic digestion to extract a higher number of viable cells, including pluripotent stem cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional gravity drainage method is used to collect umbilical cord blood, then the collection process is simple, but the number of usable stem cells obtained is insufficient
Solution Approach 1:
The patent replaces the simple gravity drainage method with a pulsatile perfusion system that uses mechanical pumping to circulate perfusate through the placental tissue. This mechanical system actively extracts cells from the tissue matrix, dramatically increasing cell recovery numbers while maintaining operational simplicity through automated circulation and collection.
Solution Approach 2:
The patent changes the physical parameters of cell extraction by introducing pulsatile flow dynamics and enzymatic digestion. The perfusion system varies flow rate and pressure dynamically to optimize cell release from tissue, while enzymatic parameters are adjusted to enhance cell detachment without damaging viability, thereby increasing total cell yield.
2Quantity of substance
If pulsatile perfusion with enzymes is used to extract cells from afterbirth tissue, then the number of viable cells obtained increases significantly, but the process complexity increases
Solution Approach 1:
The patent segments the cell extraction process into distinct functional stages: perfusate circulation through the placenta, enzymatic digestion of tissue matrix, cell separation from plasma, and cell collection. This segmentation allows each stage to be optimized independently while using standardized components, managing overall system complexity.
Solution Approach 2:
The patent introduces digestive enzymes as intermediary substances that mediate between the perfusion system and tissue cells. The enzymes facilitate cell release from the tissue matrix without requiring direct mechanical disruption, simplifying the extraction mechanism while dramatically increasing cell viability and numbers.
3Loss of time
If conventional UCB collection methods are used, then the collection process is fast, but the number of stem cells available for transplant is insufficient
Solution Approach 1:
The patent implements continuous perfusion circulation where perfusate is constantly pumped through the placental tissue, continuously releasing cells into the collection system. This continuous action maintains high cell recovery rates throughout the entire collection process, increasing total cell numbers without extending the overall collection time.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach yields significantly more viable cells, often twice as many as traditional UCB collection methods, expanding the applicability of stem cell transplants and providing a powerful tool for broader cell research, including non-hematopoietic cell types.
Implementation Method 1
extracting cells from said afterbirth tissue by pulsatile perfusion
Implementation Method 2
The method involves the steps of: a) placing the afterbirth tissue into a perfusion circuit, b) extracting cells from said afterbirth tissue by pulsatile perfusion
Data Source
AI summary
A method for extracting cells from afterbirth tissue, including placing the afterbirth into a perfusion circuit prior to exsanguination, extracting the cells from the afterbirth with digestive enzymes and mechanically recovering cells from the digested afterbirth tissue, and isolating the cells from the perfusate and digestion mix. Also disclosed is a cell line derived from afterbirth using the two-step pulsatile perfusion extraction method.


